Symptomtext
Pregnancy with no AE; Initial information received on 12-Oct-2021 regarding an unsolicited valid non-serious case received from a physician.. This case involves adult female patient who was pregnant (Exposure during pregnancy) while receiving INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT]. Data regarding this pregnancy were received prospectively, i.e, before pregnancy outcome was known. The date of last menstrual period was not reported. The estimated due date was not reported. The patient medical history included cardiac disorder, sexually transmitted disease and earning difficulties, congenital malformations, and environmental exposures. At the time of the event, the patient had ongoing thyroid disorder, asthma, and hypersensitivity. The patient medical history, medical treatment(s), vaccination(s), concomitant medication, and family history were not provided. On 11-Oct-2021, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE [lot UT7315MA and expiry date: not reported] via an intramuscular route in unknown administration site for prophylactic vaccination. On an unknown date, for the patient reported a non-serious event pregnancy (Exposure during pregnancy) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was unknown to consent to be contacted patient and patient physician. It is unknown if the patient experienced any additional symptoms/events Action taken with QUADRIVALENT INFLUENZA VACCINE was not applicable. At time of reporting, the outcome was unknown for the event pregnancy. Additionally, at time of reporting, the outcome of the pregnancy is unknown.